Full-Text Articles

Annals of the Rheumatic Diseases (ARD Online)
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
Philip J Mease, Josef S Smolen, Frank Behrens, Peter Nash, Soyi Liu Leage, Lingnan Li, Hasan Tahir, Melinda Gooderham, Eswar Krishnan, Hong Liu-Seifert, Paul Emery, Sreekumar G Pillai, Philip S Helliwell, SPIRIT H2H study group
BMJ Open
Cohort profile: the clinical 'Psoriasis in Adolescents' (PIA) cohort in Denmark
Christoffer Blegvad, Anne-Marie Nybo Andersen, Jonathan Groot, Claus Zachariae, Lone Skov
BMJ Open
Protocol for a case-control diagnostic accuracy study to develop diagnostic criteria for psoriasis in children (DIPSOC study): a multicentre study recruiting in UK paediatric dermatology clinics
Esther Burden-Teh, Ruth Murphy, Sonia Gran, Tamar Nijsten, Carolyn Hughes, Kim Suzanne Thomas
Acta Dermato-Venereologica
Quality of Life in Psoriasis Vulgaris: Use of the ItchyQoL Question-naire in a Secukinumab Phase III Trial in Patients with Psoriasis Vulgaris
Sonja Ständer, Sabine Steinke, Matthias Augustin, Dieter Metze, Karin Loser, Daniel Baeumer, Christian Sieder, Thomas Luger
BMJ Open
Prevalence of psoriasis and associated risk factors in China: protocol of a nationwide, population-based, cross-sectional study
Jing Li, Meiwen Yu, Ya-Wen Wang, Jia-An Zhang, Mei Ju, Kun Chen, Yu Jiang, Min Li, Xiang-Sheng Chen
Pediatric Rheumatology Online Journal
Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab
S Signa, E Campione, M Rusmini, S Chiesa, A Grossi, A Omenetti, R Caorsi, G M Viglizzo, M Galluzzo, L Bianchi, M Talamonti, A Orlandi, A Martini, I Ceccherini, M Gattorno
Pediatric Rheumatology Online Journal
Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents
Toni Hospach, Fabian Glowatzki, Friederike Blankenburg, Dennis Conzelmann, Christian Stirnkorb, Chris Sandra Müllerschön, Peter von den Driesch, Lisa Maria Köhler, Meino Rohlfs, Christoph Klein, Fabian Hauck
Journal of the American Academy of Dermatology
Immunogenicity and Skin Clearance Recapture in Clinical Studies of Brodalumab
Jerry Bagel, Mark Lebwohl, Robert J Israel, Abby Jacobson
Journal of the American Academy of Dermatology
Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator-controlled phase 3 AMAGINE-2 trial
Luis Puig, Mark Lebwohl, Hervé Bachelez, Jeffrey Sobell, Abby A Jacobson
Arthritis Research & Therapy
Best practices in DNA methylation: lessons from inflammatory bowel disease, psoriasis and ankylosing spondylitis
Jessica M Whyte, Jonathan J Ellis, Matthew A Brown, Tony J Kenna

Pages

Hessel H van der Zee, MD, PhD and Caitriona Ryan, MD, invite you to explore the education and resources on this site, designed to provide a comprehensive approach to managing patients with hidradenitis suppurativa.

Hessel H van der Zee, MD, PhD
Erasmus University Medical Center
Rotterdam, the Netherlands

Caitriona Ryan, MD
St. Vincent's Hospital
Dublin, Ireland


User-friendly learning modules available in short and accessible formats.

Insights and developments in HS from leading experts.

Continuously updated news and conference coverage.

Helpful resources for your practice and patients.